Curamir Therapeutics
Latest round
- Series A
Last raised
- Sep 2019
Total raised
- $10M
Investors
- 1
About Curamir Therapeutics
Founded in 2019 and based in Massachusetts, US, Curamir Therapeutics, Inc. is a biotechnology company developing miRNA-based cancer therapeutics to address chemoresistance.
Who invested in Curamir Therapeutics
1 investor across 1 round
See all investors in Curamir Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 20, 2019
Amount
$10M
Investors
Questions about Curamir Therapeutics
Who invested in Curamir Therapeutics?
Curamir Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Curamir Therapeutics raised?
Curamir Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Curamir Therapeutics last raise money?
Curamir Therapeutics's most recent round on record is a Series A, in Sep 2019.
What does Curamir Therapeutics do?
Founded in 2019 and based in Massachusetts, US, Curamir Therapeutics, Inc.
Where is Curamir Therapeutics headquartered?
Curamir Therapeutics is headquartered in Woburn, US.
Which VCs invest in companies like Curamir Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Curamir Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Curamir Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.